Modifying the Glycocalyx of Melanoma Cells via Metabolic Glycoengineering Using N-Acetyl-d-glucosamine Analogues
Cells · 2024
DOI: 10.3390/cells13221831 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von David Harris und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry, Friedrich Alexander University Erlangen-Nürnberg, Fahrstrasse 17, 91054 Erlangen, Germany. Hauptthemen laut MEDLINE: Glycocalyx, Melanoma, Acetylglucosamine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation.
Abstract (Originalsprache)
Tumor cells are decorated with aberrant glycan structures on cell surfaces. It is well known that the glycocalyx serves as a main cellular regulator, although its role in cancer is still not completely understood. Over recent decades, several non-natural monosaccharides carrying clickable groups have been introduced in melanoma cells. This technique, called Metabolic Glycoengineering (MGE), opens up the possibility of altering the cell’s glycocalyx via click chemistry using a two-step approach. This study expands the field of MGE by showing the successful metabolic incorporation of novel alternative artificial glucosamine derivatives. The latter were either deoxygenated or blocked by methyl ether in position 4 to generate deficient glycosylation patterns, while being extended by an alkyne to enable click chemistry as a one-step approach. As a result, we observed a reduced proliferation rate of melanoma cells. Furthermore, using a lectin array, the decrease in high mannose epitopes was observed. In summary, the successful use of alternative artificial glucosamine derivatives enabled a significant alteration in the glycocalyx, consequently influencing cell behavior.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biochemistry, Friedrich Alexander University Erlangen-Nürnberg, Fahrstrasse 17, 91054 Erlangen, Germany.
- Institute of Organic Chemistry, Julius-Maximilians-University of Würzburg, Am Hubland, 97074 Würzburg, Germany.
- Department of Musculoskeletal Tissue Regeneration, Orthopedic Clinic König-Ludwig Haus, Julius-Maximilians-University of Würzburg, Friedrich-Bergius-Ring 15, 97076 Würzburg, Germany.
ORCID-Profile: Sebastian Staebler, Regina Ebert, Anja Katrin Boßerhoff
Förderung
- German Research Foundation
Zitieren
APA
Harris, D., Groß, M., Staebler, S., Ebert, R., Seibel, J., & Boßerhoff, A. K. (2024). Modifying the Glycocalyx of Melanoma Cells via Metabolic Glycoengineering Using N-Acetyl-d-glucosamine Analogues. Cells. https://doi.org/10.3390/cells13221831
Vancouver
Harris D, Groß M, Staebler S, Ebert R, Seibel J, Boßerhoff AK. Modifying the Glycocalyx of Melanoma Cells via Metabolic Glycoengineering Using N-Acetyl-d-glucosamine Analogues. Cells. 2024. doi:10.3390/cells13221831
BibTeX
@article{Harris2024,
author = {Harris, David and Groß, Marcel and Staebler, Sebastian and Ebert, Regina and Seibel, Jürgen and Boßerhoff, Anja Katrin},
title = {Modifying the Glycocalyx of Melanoma Cells via Metabolic Glycoengineering Using N-Acetyl-d-glucosamine Analogues},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13221831}
}
EUVIMED